Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000911420-24-000092
Filing Date
2024-04-17
Accepted
2024-04-17 12:36:08
Documents
1
Effectiveness Date
2024-04-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10491
  Complete submission text file 0000911420-24-000092.txt   11636
Mailing Address C/O ORBIMED ADVISORS 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 972 73 2822600
Exsilio Therapeutics Inc. (Filer) CIK: 0002020048 (see all company filings)

EIN.: 880954191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-510828 | Film No.: 24850014